Table 1 Clinical characteristics and incidence of acute rejection in 160 RT patients
Variable | Value |
|---|---|
Recipient age (years), median (IQR) | 36.3 (20–44) |
Donor age (years), median (IQR) | 29 (26-34.3) |
Male sex, n (%) | 113 (70.6) |
Pre-transplant kidney disease, n (%) | |
Glomerular disease | 148 (92.5) |
Pyelonephritis | 6 (3.8) |
Nephrotic Syndrome | 1 (0.6) |
IgA nephropathy | 1 (0.6) |
Systemic lupus erythematosus | 1 (0.6) |
Previous dialysis, n (%) | 143 (89.4) |
Type of donor, n (%) | |
Living unrelated | 142 (88.8) |
Living related | 17 (10.6) |
Deceased | 1 (0.6) |
PRA > 0 (%), n (%) | 33 (20.6) |
HLA mismatches, n (%) | |
0 | 4 (2.5) |
1–4 | 128 (80.5) |
5–6 | 27 (17.0) |
High immunologic risk, n (%) | 37 (23.1) |
Induction therapy, n (%) | |
No | 1 (0.6) |
IL-2 antibody | 159 (99.4) |
Acute rejection, n (%) | |
In first year | 19 (11.9) |
In first month | 14 (8.8) |